GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avacta Group PLC (OTCPK:AVCTF) » Definitions » Cash-to-Debt

AVCTF (Avacta Group) Cash-to-Debt : 1.46 (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Avacta Group Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Avacta Group's cash to debt ratio for the quarter that ended in Jun. 2024 was 1.46.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Avacta Group could pay off its debt using the cash in hand for the quarter that ended in Jun. 2024.

The historical rank and industry rank for Avacta Group's Cash-to-Debt or its related term are showing as below:

AVCTF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.71   Med: No Debt   Max: No Debt
Current: 1.46

During the past 13 years, Avacta Group's highest Cash to Debt Ratio was No Debt. The lowest was 0.71. And the median was No Debt.

AVCTF's Cash-to-Debt is ranked worse than
70.32% of 1486 companies
in the Biotechnology industry
Industry Median: 6.795 vs AVCTF: 1.46

Avacta Group Cash-to-Debt Historical Data

The historical data trend for Avacta Group's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Avacta Group Cash-to-Debt Chart

Avacta Group Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only No Debt 23.46 15.38 1.75 0.71

Avacta Group Semi-Annual Data
Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.52 1.75 1.16 0.71 1.46

Competitive Comparison of Avacta Group's Cash-to-Debt

For the Biotechnology subindustry, Avacta Group's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avacta Group's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avacta Group's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Avacta Group's Cash-to-Debt falls into.



Avacta Group Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Avacta Group's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Avacta Group's Cash to Debt Ratio for the quarter that ended in Jun. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avacta Group  (OTCPK:AVCTF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Avacta Group Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Avacta Group's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Avacta Group Business Description

Traded in Other Exchanges
Address
Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, GBR, LS23 7FA
Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.

Avacta Group Headlines

From GuruFocus

Avacta Group plc Signs License Agreement With Astrea Bioseparations

By Business Wire Business Wire 12-21-2020

Avacta Selects Second pre|CISION� Pro-drug Candidate for Development

By Business Wire Business Wire 01-18-2022

First Patient Dosed in the US in Avacta's AVA6000 Phase 1 Clinical Study

By Business Wire Business Wire 04-27-2023

Avacta Appoints Dr Christina Coughlin as Non-Executive Director

By Business Wire Business Wire 03-21-2022

Avacta and Mologic Announce Commercial Partnership

By Business Wire Business Wire 02-08-2021

Avacta announces AffyXell $7.3 Million Series A Financing

By Business Wire Business Wire 02-01-2021